|
|
Article: Supplying flu drugs, developing vaccine pose challenges, present quandaries.(Food & Drug)
- Article from:
- Inspection Monitor
- Article date:
- May 1, 2009
CopyrightCOPYRIGHT 2009 Washington Information Source, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Even as FDA, in response to requests from the U.S. Centers for Disease Control, issued Emergency Use Authorizations (EUAs) to make available to public health and medical personnel diagnostic and therapeutic tools to identify and respond to the swine flu virus, news broke that some states have not stockpiled sufficient supplies of these drugs to meet potential demand should swine flu truly reach epidemic proportions.
FDA issued these EUAs for the use of certain Relenza and Tamiflu antiviral products, and for the rRTPCR Swine Flu Panel diagnostic test.
The EUA authority allows FDA to authorize the use of unapproved or uncleared medical products or ...